Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
Nhs Blood & Transplant
500-600 North Bristol Park, Northway Bristol, Filton
BRISTOL
BS347QH
UK
E-mail: marta.drozdzowska@nhsbt.nhs.uk
NUTS: UK
Internet address(es)
Main address: https://www.nhsbt.nhs.uk/
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Support of existing NHSBT Extracorporeal Photopheresis (ECP) systems
Reference number: NHSBT1366 / C39664
II.1.2) Main CPV code
33140000
II.1.3) Type of contract
Supplies
II.1.4) Short description
The award is for Support of existing NHSBT Extracorporeal Photopheresis (ECP) systems
Contract notice published on 10th March 2021 with publication reference: 2021/S 000-004888.
Please see section II.2.4 for detailed description of the procurement.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
3 050 000.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
33693000
50421000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Included in the TAS portfolio of therapeutic procedures is Extracorporeal Photopheresis (ECP) which is provided from four of the TAS hub units (Bristol, London, Oxford, and Manchester) as well as all three of the spoke sites (the Clatterbridge Cancer Centre, Cardiff and The Vale Health Board and Plymouth University Hospitals Trust). The ECP system's utilised by the TAS teams are able to perform both adult and paediatric procedures and have an integral clinical grade light box.
The requirement for this procurement was to source machine consumables and maintenance services to support existing Extracorporeal Photopheresis machine platforms. Contract notice published on 10th March 2021 with publication reference: 2021/S 000-004888.
As a result of the tender, a Framework Agreement for Support of existing NHSBT Extracorporeal Photopheresis (ECP) systems for a period of 2 years with two 1-year options to extend has been awarded to Therakos (UK) Ltd.
The following contracting authorities will be able to purchase against the Framework Agreement: NHSBT and Scottish National Blood Transfusion Service.
II.2.5) Award criteria
Price
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2020/S 230-568414
Section V: Award of contract
Contract No: NHSBT1366 / C39664
Title: Support of existing NHSBT Extracorporeal Photopheresis (ECP) systems
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
01/08/2021
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Therakos (UK) Ltd
Staines
TW18 3AG
UK
NUTS: UK
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 3 050 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
NHS Blood and Transplant
Bristol
UK
VI.5) Date of dispatch of this notice
11/08/2021